ロード中...
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
As patents on many high-selling biological medicines are expiring, non-innovator versions, such as biosimilars, may enter this multi-billion dollar market. This study aims to map patents and patent applications for innovator as well as biosimilar monoclonal antibodies in Europe, and investigates leg...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2020-01-01
|
| シリーズ: | mAbs |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/19420862.2020.1743517 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|